当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析

济川药业

(600566)

  

流通市值:252.56亿  总市值:254.21亿
流通股本:9.16亿   总股本:9.22亿

济川药业(600566)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润19.07亿元,每股收益2.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1409513.57万元,未分配利润955454.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1815177.62万元,负债405664.05万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入5,805,134,511.24,034,400,209.972,402,545,954.329,654,537,192.67
营业总成本3,879,965,357.382,717,305,015.541,594,276,317.546,516,457,726.29
营业利润2,119,657,580.921,457,791,851.67885,925,169.463,258,135,771.8
利润总额2,233,497,637.21,567,658,696.03989,790,164.223,297,089,590.2
净利润1,907,346,070.631,341,293,924.9846,787,304.112,827,062,991.25
其他综合收益----
综合收益总额1,907,346,070.631,341,293,924.9846,787,304.112,827,062,991.25
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计14,349,997,698.3414,220,305,969.6515,497,144,274.9314,235,429,851.57
非流动资产合计3,801,778,486.463,829,257,623.543,864,261,093.233,908,264,726.95
资产总计18,151,776,184.818,049,563,593.1919,361,405,368.1618,143,694,578.52
流动负债合计3,853,827,559.34,324,975,644.584,961,751,163.64,591,861,830.43
非流动负债合计202,812,952.7193,714,003184,244,965.97182,970,240.43
负债合计4,056,640,5124,518,689,647.585,145,996,129.574,774,832,070.86
归属于母公司股东权益合计14,071,197,838.7813,508,465,658.8614,194,467,077.8913,349,441,189.41
股东权益合计14,095,135,672.813,530,873,945.6114,215,409,238.5913,368,862,507.66
负债和股东权益合计18,151,776,184.818,049,563,593.1919,361,405,368.1618,143,694,578.52
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计7,739,228,359.65,820,320,494.263,706,314,397.211,205,969,408.5
经营活动现金流出小计5,999,715,661.264,253,044,328.182,367,511,844.137,742,010,772.67
经营活动产生的现金流量净额1,739,512,698.341,567,276,166.081,338,802,553.073,463,958,635.83
投资活动现金流入小计2,745,625,237.742,460,034,964.492,118,896,311.814,743,416,960.59
投资活动现金流出小计4,822,222,826.314,515,635,215.97455,347,903.795,137,644,623.9
投资活动产生的现金流量净额-2,076,597,588.57-2,055,600,251.481,663,548,408.02-394,227,663.31
筹资活动现金流入小计1,159,785,934.41787,815,312.94667,379,039.431,109,641,517.49
筹资活动现金流出小计2,037,620,537.421,561,160,398.4415,633,131.221,260,330,526.82
筹资活动产生的现金流量净额-877,834,603.01-773,345,085.5651,745,908.21-150,689,009.33
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-1,214,919,493.24-1,261,669,170.93,654,096,869.32,919,041,963.19
期末现金及现金等价物余额6,523,063,316.846,476,313,639.1811,392,079,679.387,737,982,810.08
最新报告期:2024-11-05
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
兴业证券孙媛媛2.863.223.632024-11-05
长城证券刘鹏,蔡航2.883.173.472024-11-04
国泰君安丁丹2.923.303.692024-11-03
浙商证券孙建2.983.353.822024-10-31
TOP↑